Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Total Debt of $760.0 million for Q1 2026, up 41.53% year-over-year from $537.0 million in Q1 2025, and up 41.53% quarter-over-quarter from $537.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Total Debt history runs 10 years deep, the most recent figure standing at $760.0 million for Q1 2026.
- In Q1 2026, Total Debt rose 41.53% year-over-year to $760.0 million; the TTM figure through Mar 2026 stood at $760.0 million (up 41.53% YoY), while the FY2026 annual figure was $760.0 million, up 41.53% from the prior year.
- Total Debt for Q1 2026 stood at $760.0 million, up from $537.0 million in the prior quarter.
- The five-year high for Total Debt was $760.0 million in Q1 2026, with the low at $88.0 million in Q1 2024.
- The 5-year median for Total Debt is $106.0 million (2023), against an average of $316.0 million.
- The sharpest annual moves came in 2024 and 2025: Total Debt declined 16.98% in 2024, then surged 510.23% in 2025.
- Dr Reddys Laboratories' Total Debt stood at $89.0 million in 2022, then advanced by 19.1% to $106.0 million in 2023, then retreated by 16.98% to $88.0 million in 2024, then soared by 510.23% to $537.0 million in 2025, then jumped by 41.53% to $760.0 million in 2026.
- Business Quant data shows RDY's Total Debt at $760.0 million in Q1 2026, $537.0 million in Q1 2025, and $88.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 760.00 Mn |
| 10 | Alkermes | 8.15 Bn | 7.50 Bn | 397.90 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 760.00 Mn |
| Mar 31, 2025 | 537.00 Mn |
| Mar 31, 2024 | 88.00 Mn |
| Mar 31, 2023 | 106.00 Mn |
| Mar 31, 2022 | 89.00 Mn |
| Mar 31, 2021 | 98.00 Mn |
| Mar 31, 2020 | 74.00 Mn |
| Mar 31, 2019 | 380.00 Mn |
| Mar 31, 2018 | 386.00 Mn |
| Dec 31, 2009 | 150.00 Mn |
| Sep 30, 2009 | 174.00 Mn |
| Jun 30, 2009 | 191.00 Mn |